DYN CIK: 1818794

Dyne Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.27
FY23:
0.13
FY24:
0.66
FY25:
1.13
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.04
FY22:
0.04
FY23:
0.04
FY24:
0.03
FY25:
0.06
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.43
FY22:
0.31
FY23:
0.17
FY24:
0.69
FY25:
1.19

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.03
FY23:
0.05
FY24:
0.04
FY25:
0.05
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.03
FY23:
0.02
FY24:
0.02
FY25:
0.16
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
0.25
FY23:
0.09
FY24:
0.63
FY25:
0.97
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.43
FY22:
0.31
FY23:
0.17
FY24:
0.69
FY25:
1.19

All amounts in billions USD Data source:SEC EDGAR